GlaxoSmithKline S.A.E. (BIOC) trades on the Egyptian Exchange (EGX) in the Distribution Services sector. Last updated 10 Sept 2026, 21:08 (Cairo time). EGX sector classification: Health Care & Pharmaceuticals.
What is GlaxoSmithKline S.A.E.’s share price today? BIOC last traded at EGP 289.1 (-5.21% on the day), for a market value of EGP 25.47 billion and a dividend yield of 0.33%. Its 52-week range is EGP 58.03 to 550.
Total return based on EGX closing prices. Past performance does not indicate future results.
GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals.The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt.GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.
Data as of 10 Sept 2026, 21:08 (Cairo time). Source: Egyptian Exchange via TradingView; financial statements via Yahoo Finance. Prices refresh every 15 minutes during EGX trading hours (Sun–Thu).